Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual FSH/HCG Triggering to Improve IUI Success in Unexplained Infertility
IRCT20220702055335N2Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Aug 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of follitropin and human chorionic gonadotropin in female infertility, sponsored by Tabriz University of Medical Sciences. Started Aug 2022; status: completed.
02
Drugs
follitropinhuman chorionic gonadotropin
03
Conditions
female infertility
Beyond the preview
Go deeper on IRCT20220702055335N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220702055335N2.